Positive Health Online
Your Country
Research: HELPMAN and COLLEAGUES,
Listed in Issue 211
Abstract
HELPMAN and COLLEAGUES, Princess Margaret Hospital, University Health Network, University of Toronto, Ontario, Canada. limorh@tasmc.health.gov.il evaluated attitudes toward complementary and alternative medicine (CAM) use in 2 populations of women receiving chemotherapy for epithelial ovarian cancer (EOC).
Background
Methodology
Women with EOC currently being treated with chemotherapy at 2 tertiary cancer centres, in Canada and the United Kingdom, completed a self-administered questionnaire on attitudes and perceptions of CAM and types of CAM used within the previous month.
Results
One hundred ninety-two patients (94 from Canada, 98 from United Kingdom) completed the questionnaire. Overall, 85 women (44%) were identified as CAM users. Complementary and alternative medicine use was more common among Canadian women (52%) compared with women from the United Kingdom (37%), P = 0.02. Participants used 71 different types of CAM, the majority (61%) taking multiple CAM. The frequency of CAM use was the same in primary compared with recurrent disease. Eighty-nine percent of CAM users considered it important for their oncologist to be aware of CAM use. Canadian women, however, were less likely to inform their physician (Canada: 50%; United Kingdom: 81%), P = 0.02. Motivations for CAM use were the same in both populations including assist healing (60%), boost the immune system (57%), improve quality of life (48%), and relieve symptoms (45%). Thirteen percent thought CAM could cure cancer, whereas 17% thought it would prevent recurrence.
Conclusion
Complementary and alternative medicine use is common in women receiving chemotherapy for EOC. Increasingly, interactions between CAM and prescribed medication are being identified. Oncologists should be aware and actively inquire about CAM use. Although patterns of CAM use differed, the motivation for starting CAM was similar, highlighting the need to address supportive care in all patients.
References
Helpman L, Ferguson SE, Mackean M, Rana A, Le L, Atkinson MA, Rogerson A and Mackay H. Complementary and alternative medicine use among women receiving chemotherapy for ovarian cancer in 2 patient populations. International Journal of Gynecological Cancer. 21(3): 587-93. Apr 2011.
Comment
The division of cancer treatments into conventional, i.e. surgery, chemotherapy and radiotherapy and complementary, i.e. nutritional, herbal, healing categories has long been criticized by this researcher. The motivations among cancer patients that other than conventional treatments could be immune-enhancing, improve quality of life and relieve symptoms are sensible and understandable in light of evidence for these treatment approaches. The lack of understanding and inability to engage in other than conventional treatments by oncologists is where further education needs to be directed.